Connection
Elaine Morrato to Drug Labeling
This is a "connection" page, showing publications Elaine Morrato has written about Drug Labeling.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.226 |
|
|
|
-
Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, Newcomer JW. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. Arch Gen Psychiatry. 2010 Jan; 67(1):17-24.
Score: 0.083
-
Morrato EH, Libby AM, Orton HD, Degruy FV, Brent DA, Allen R, Valuck RJ. Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry. 2008 Jan; 165(1):42-50.
Score: 0.072
-
Valuck RJ, Libby AM, Orton HD, Morrato EH, Allen R, Baldessarini RJ. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry. 2007 Aug; 164(8):1198-205.
Score: 0.071